🇺🇸

US SEC Filing Intelligence

· daily

New Drug Approvals (Original) — July 31, 2026

This digest covers 22 FDA approvals from July 27-29, 2026, all classified as 'Other' (non-NME, non-biosimilar, non-label-expansion). The dominant theme is a massive wave of generic/biosimilar competition for SUGAMMADEX SODIUM, with 11 separate approvals granted to sponsors including HIKMA, TEVA, SANDOZ, SUN PHARM, MYLAN, LUPIN, and others, signaling an imminent and severe revenue erosion event for the originator (Merck's BRIDION). The highest-conviction bullish signals are four label expansions for CLONIDINE HYDROCHLORIDE (CMP DEV LLC), Ruxolitinib (APOTEX), and two undisclosed drugs from FRESENIUS KABI USA and VIATRIS SPECIALTY, though their commercial materiality is low. The key risk is the complete absence of NME approvals, indicating a quiet period for innovative drug catalysts, while the SUGAMMADEX SODIUM cluster is the single most impactful event for generic manufacturers and a bearish signal for the originator.

22 total filings
· daily

DHS Homeland Security Contracts — July 31, 2026

This digest covers a single, large civilian contract from the Department of Homeland Security (DHS) to Serco Services Inc. worth $321.3 million, representing the entire $321.3 million aggregate obligation for the period. The contract, awarded in 2009 and completed in 2016, is a historical artifact with zero current outlays, providing no actionable forward-looking revenue signal for Serco. The neutral signal strength (4/10) and low materiality (2/10) reflect the contract's expired status and mature, low-margin administrative services nature. The key risk is the lack of current DHS contract data for Serco, creating a visibility gap on its civilian backlog, while the key watch item is any potential follow-on or recompete for USCIS National Benefits Center support.

1 total filings
· daily

New Federal Contractors — July 31, 2026

This digest covers four civilian agency contracts totaling $1.07 billion in obligations, with zero defense-related awards. The dominant theme is stable, low-margin federal services across environmental remediation (DOE), administrative support (DHS), engineering R&D (NASA), and clinical research (NIH). The highest-conviction signal is a $173.3 million NIH contract to Technical Resources International, Inc., a small, woman-owned business, offering predictable long-term revenue through 2026. However, three of the four contracts are either completed or near-expiration, limiting near-term revenue visibility. Key risk: the $321.3 million Serco Services Inc. DHS contract is expired with $0 outlayed, signaling no current contribution from that award.

4 total filings
· daily

Significant Contract Modifications ($10M+) — July 31, 2026

This digest covers $1.07 billion in federal contract modifications, all from civilian agencies (0% defense), signaling a concentrated investment opportunity in environmental remediation and health R&D services. The dominant theme is long-duration, cost-plus federal work at the Department of Energy (Hanford cleanup) and the National Institutes of Health (clinical research), where pricing risk is low but revenue visibility varies. The highest-conviction signal is Technical Resources International, Inc.'s $173.3 million NIH contract, which provides a stable, nearly decade-long revenue stream through 2026. A key risk is the short duration of Central Plateau Cleanup Company's $371.6 million DOE award, which limits near-term revenue recognition and exposes the contractor to option-exercise uncertainty.

4 total filings
· daily

Contract Deobligations Alert — July 31, 2026

This digest covers $1.07 billion in federal contract obligations from July 31, 2026, with zero defense-related awards, underscoring a purely civilian procurement theme. The dominant sector is environmental remediation, led by a $371.6 million DOE Hanford award to Central Plateau Cleanup Company (PAE-Parsons), though its short duration and low outlay limit near-term impact. The highest-conviction signal is a $173.3 million NIH clinical research contract to Technical Resources International, offering a stable, long-term revenue stream through 2026. Key risks include the expiration of a $321.3 million Serco DHS contract with no current outlay and the completion of a $202.6 million NASA engineering award to Millennium Engineering, both reducing current revenue visibility for those firms.

4 total filings
· daily

Contract Option Exercises — July 31, 2026

This digest covers $1.07 billion in contract option exercises from July 31, 2026, all from civilian agencies (0% defense-related), with an average signal strength of 5.0/10. The dominant theme is federal environmental remediation and health R&D services, led by a $371.6 million DOE Hanford cleanup award to Central Plateau Cleanup Company (PAE-Parsons) and a $173.3 million NIH clinical research contract to Technical Resources International. The highest-conviction signal is the bullish, long-duration NIH contract to Technical Resources International, which provides stable, low-risk revenue through 2026. A key risk is the short 8-month performance period and low outlay ($125.4M) on the largest contract, limiting near-term revenue visibility for PAE-Parsons.

4 total filings
· daily

All HHS Contracts — July 31, 2026

The sole contract in this digest is a $173.3 million cost-plus-fixed-fee award from the National Institutes of Health (NIH) to Technical Resources International, Inc. for clinical research operations and management support (CROMS), spanning 2017-2026. This is a purely civilian award with no defense-related content, underscoring NIH's sustained investment in health R&D services. The highest-conviction signal is the low pricing risk and long-term revenue stability afforded by the cost-plus structure, providing predictable margins for a small business. Key watch items include potential contract modifications or extensions beyond July 2026 and the company's ability to scale operations given its small business status.

1 total filings
· daily

All DOE Contracts — July 31, 2026

This digest covers a single Department of Energy (DOE) contract totaling $371.6 million, with zero defense-related content, underscoring a purely civilian environmental remediation theme. The dominant signal is neutral: Central Plateau Cleanup Company, LLC (a PAE-Parsons joint venture) received a cost-plus award fee delivery order for Hanford site cleanup, but the short 8-month performance period and low outlay-to-obligation ratio ($125.4M out of $371.6M) limit near-term revenue visibility. The highest-conviction signal is the sustained DOE commitment to legacy nuclear waste remediation, though the cost-plus structure caps profit upside. A key risk is the contract’s expiration on September 30, 2021, with no guarantee of option exercise, creating a binary event for PAE-Parsons’ DOE revenue stream.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — July 31, 2026

This digest covers $1.07 billion in federal contract obligations, all from civilian agencies, with zero defense exposure. The dominant theme is long-duration, cost-plus environmental and health R&D services, led by a $371.6 million DOE Hanford cleanup award to Central Plateau Cleanup Company (PAE-Parsons) and a $173.3 million NIH clinical research contract to Technical Resources International. The highest-conviction signal is the bullish, decade-long NIH award to Technical Resources International, which offers stable, low-risk revenue for a small, woman-owned business. A key risk is the short 8-month performance period on the largest contract (DOE/Hanford), limiting near-term revenue visibility despite the high obligation amount.

4 total filings
· daily

High-Value Federal Grants ($5M+) — July 31, 2026

This digest covers $1.07 billion in aggregate obligations across four civilian agency contracts, with zero defense exposure. The dominant theme is stable, cost-plus-funded environmental and administrative services, led by a $371.6 million DOE Hanford cleanup award to Central Plateau Cleanup Company (PAE-Parsons) and a $321.3 million DHS records support contract to Serco Services Inc. The highest-conviction signal is a bullish $173.3 million NIH clinical research contract to Technical Resources International, offering long-term, low-risk revenue through 2026. However, three of four contracts are either expired or near completion, limiting near-term revenue visibility. Key risk: the Serco and Millennium Engineering contracts are fully completed with no current financial impact, inflating the aggregate value relative to active revenue streams.

4 total filings
· daily

DOE Energy Grants — July 31, 2026

This digest covers a single, large civilian contract from the Department of Energy (DOE), a $371.6 million cost-plus award fee delivery order awarded to Central Plateau Cleanup Company, LLC (a PAE-Parsons joint venture) for remediation at the Hanford site. With zero defense-related awards, the signal is purely civilian and neutral, reflecting stable but non-transformational federal environmental spending. The highest-conviction signal is the contract's short 8-month performance period and cost-plus structure, which limits margin upside and revenue visibility despite the headline value. A key risk is that only $125.4 million has been outlaid against the obligation, suggesting potential funding flow delays or execution headwinds.

1 total filings
· daily

General Federal Contracts — July 31, 2026

Across four general federal contracts valued at $1.07 billion, all are civilian (0% defense), signaling a concentrated civilian agency theme. The Department of Energy’s $371.6 million remediation contract at Hanford (Central Plateau Cleanup Company, a PAE-Parsons subsidiary) commands the highest materiality, though its short 8-month performance period and low outlay ($125M) limit near-term visibility. The only bullish signal with high conviction is Technical Resources International, Inc.’s $173.3 million clinical research support contract with NIH, offering a stable, nearly decade-long revenue stream for a small, woman-owned contractor. Key risk: the Serco Services Inc. $321.3 million DHS contract is expired and has no current financial impact, but its past scale highlights Serco’s enduring administrative service footprint. Investors should watch for option exercises on the DOE contract and NIH re-competes for Technical Resources.

4 total filings
· daily

All NASA Contracts — July 31, 2026

The sole NASA contract in this period, a $202.6 million cost-plus-fixed-fee award to MILLENNIUM ENGINEERING AND INTEGRATION SERVICES, LLC, is a legacy contract completed in 2021, offering no current revenue visibility. The aggregate is entirely civilian, with zero defense exposure, and the neutral signal strength (4/10) reflects the contract's age and lack of ongoing materiality. The highest-conviction signal is the absence of new awards, indicating a potential gap in NASA's engineering support spending at Ames Research Center. Key risk is the lack of a follow-on contract, which could signal a shift in NASA's procurement strategy or a loss of competitive position for the small business.

1 total filings
· daily

S&P 500 Technology Sector SEC Filings — July 31, 2026

The S&P 500 Technology sector shows a bifurcated landscape this period. Apple Inc. delivered a standout performance with 16% YoY revenue growth and a 27% surge in net income, driven by iPhone, Mac, and Services, while its balance sheet strengthened significantly with a 45.8% increase in shareholders' equity. However, insider activity signals caution: a top executive at Accenture sold $577K under a 10b5-1 plan, and Adobe's SVP & CAO sold shares, suggesting profit-taking or internal caution. Passive institutional ownership remains strong, with Vanguard confirming 7.63% and 5.52% stakes in Marvell Technology and Autodesk, respectively. Qualcomm's filing relates to the Modular Inc. acquisition, a non-operational event. Overall, the sector is characterized by strong operational performance at scale (Apple) but mixed signals from insider transactions, warranting a selective approach. The lack of forward-looking guidance or period-over-period comparisons in most filings limits trend analysis, but Apple's data provides a clear positive anchor.

6 high priority 3 medium 9 total filings
· daily

Nasdaq 100 Stocks SEC Filings — July 31, 2026

The 14 filings from NASDAQ-100 constituents reveal a mixed picture of strong operational performance offset by rising capital intensity and insider caution. Amazon and Apple posted robust revenue growth of 19.6% and 16% YoY respectively, with Apple's net income surging 27% YoY, but Amazon's free cash flow remains negative due to $173B in trailing capex. Linde showed solid 9% sales growth but experienced margin compression across all segments (50-120 bps), while raising full-year EPS guidance to $17.70-$17.90. Insider activity is predominantly negative, with three separate insider sales at ADP, Adobe, and Intuitive Surgical, though two Intuit directors exercised options at $529.97, signaling confidence. The most critical development is Amazon's $90/share acquisition of Globalstar, structured as a tax-free reorganization with regulatory and operational milestones pending. A major cybersecurity incident at Amgen involving exfiltration of proprietary data and patient PHI represents a significant risk. Capital allocation trends show increased share repurchases and dividends at Linde, while Apple's shareholders' equity surged 45.8% as retained earnings turned positive. Overall, the portfolio shows strong top-line growth but faces headwinds from cost inflation, heavy investment cycles, and selective insider selling.

11 high priority 3 medium 14 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — July 31, 2026

The July 31, 2026 filings reveal a significant divergence in institutional and activist activity. Vanguard Capital Management made a broad, passive push across 25+ companies, crossing the 5% threshold in 16 names (e.g., Compass, Anavex, Conagra) while reducing or exiting positions in 8 others (e.g., Associated Banc-Corp, Chatham Lodging), signaling a portfolio rotation. Activist activity is concentrated in Scully Royalty Ltd., where the Kellogg group (35.5% stake) and Neil Subin (13.0%) are engaged in a proxy fight and litigation over the 2025 AGM, creating a high-stakes control battle. Capital World Investors maintained its 34.9% stake in Diebold Nixdorf, while RA Capital executed a strategic exchange of shares for pre-funded warrants at Inhibikase Therapeutics to cap ownership at 9.99%. Insider selling is notable at Sanara MedTech (complete exit by Tall Pines Capital) and Diana Shipping (stake fell below 5%). The overall theme is one of passive rebalancing by Vanguard, mixed with targeted activist pressure and strategic positioning by specialized funds.

9 high priority 41 medium 50 total filings
· daily

S&P 500 Financials Sector SEC Filings — July 31, 2026

The S&P 500 Financials sector is experiencing a notable bifurcation between strong earnings growth at scale and underlying capital flow challenges. Bank of America and Truist reported double-digit net income growth (26.5% and 25.2% YoY, respectively), driven by robust non-interest income and improved efficiency ratios. However, asset managers like T. Rowe Price confront a significant divergence between record AUM ($1.9T, up 12.9% YoY) and persistent net client outflows ($6.5B in Q2 2026), signaling potential revenue headwinds from fee compression and asset mix shifts. Insider trading activity provides a powerful contrarian signal: a Vice Chair at Visa executed a large $13.6M stock sale following option exercises, while an executive at Marsh & McLennan made a smaller but notable sale. Capital deployment remains aggressive, with T. Rowe Price returning $441M to shareholders and Truist executing substantial buybacks that reduced equity. The Interactive Brokers' shelf takedowns suggest ongoing capital market activity, while weak insider filings (Coinbase) create noise. The key takeaway is that top-line growth is masking idiosyncratic risks in asset management and potential insider sentiment divergence in payments.

5 high priority 4 medium 9 total filings
· daily

S&P 500 Energy Sector SEC Filings — July 31, 2026

The S&P 500 Energy sector is experiencing a powerful earnings boom driven by surging commodity prices, with Brent crude averaging $104/BBL in Q2 2026 versus $68/BBL a year ago. Chevron and ExxonMobil both reported massive year-over-year earnings increases, with Chevron's net income surging from $2.5B to $12.1B and ExxonMobil posting a 247% sequential GAAP earnings jump. However, the picture is nuanced: U.S. natural gas realizations have collapsed to $0.91/MCF from $1.75/MCF, and downstream demand is weakening, with refined product sales falling 13% internationally and 4% in the U.S. Vanguard's passive 13G filings for Devon Energy, SLB, and Valero signal continued institutional confidence in the sector's long-term value, while a small insider purchase at Texas Pacific Land Corp suggests management alignment. The key portfolio-level theme is a tale of two markets: upstream producers are thriving on high oil prices, but downstream and natural gas segments face headwinds from demand destruction and supply disruptions.

1 high priority 5 medium 6 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — July 31, 2026

The S&P 500 Consumer Staples sector is showing a clear bifurcation in Q2 2026: companies with strong brand portfolios and e-commerce capabilities (Church & Dwight, Colgate-Palmolive) are delivering organic growth and margin expansion, while those facing portfolio restructuring or regional weakness are seeing profit compression. Church & Dwight stands out with organic sales growth of 5.8% and a 22.7% surge in global e-commerce, now representing over a quarter of sales, but reported net sales were flat due to strategic portfolio actions. Colgate-Palmolive reported a 4.9% net sales increase with a 140 bps gross margin expansion to 61.5%, yet GAAP EPS fell 5% due to restructuring costs, and North America sales declined 3.0%. Both companies are increasing shareholder returns via dividends and buybacks, signaling management confidence, but rising long-term debt at Colgate ($7.8B vs $6.9B) and a sharp cash decline at Church & Dwight ($254.8M from $409.0M) due to a $300M acquisition warrant caution. The passive 5%+ stakes disclosed by Vanguard in Dollar General and Estee Lauder suggest institutional accumulation in undervalued staples names, but provide no operational signals. The overarching theme is that operational excellence and digital transformation are driving outperformance, while legacy portfolio issues and regional headwinds are creating divergence within the sector.

2 high priority 4 medium 6 total filings
· daily

S&P 500 Industrials Sector SEC Filings — July 31, 2026

The six filings reveal a bifurcated industrial landscape: Eaton Corp's record top-line growth (21% YoY) and raised guidance signal robust demand in electrical markets, but this is overshadowed by a 16.4% GAAP net income decline, 80 bps YoY margin compression, and a massive debt-fueled acquisition spree ($11B in cash for acquisitions, debt up 111% to $18.5B). The Mobility segment's organic sales decline (-2% YoY) and eMobility's -13.7% drop highlight a weak spot, prompting the planned separation via Reverse Morris Trust. Insider selling at ADP ($280K by a Corp VP under a 10b5-1 plan) is a minor negative signal. Meanwhile, Vanguard's 13G filings for Honeywell Aerospace (7.54% stake) and FedEx Freight (5.5% stake) confirm passive institutional accumulation in two newly spun-off or pure-play industrial names, suggesting a sector rotation toward simpler, high-quality assets. The overarching theme is a 'growth vs. quality' trade-off: Eaton is buying growth at the expense of balance sheet strength and margins, while Vanguard's passive bets favor clean, capital-light structures.

3 high priority 3 medium 6 total filings